FFilingSight

Sherwin-Williams (SHW) 10-K Red Flags

Risk signals extracted deterministically from Sherwin-Williams’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (9)

  • Receivables outpacing revenue: Accounts receivable grew +16.8% YoY vs revenue growth of +2.1%. The +14.8% spread suggests extended credit terms, channel stuffing risk, or collection deterioration. Investigate the allowance for doubtful accounts and DSO trend.
  • Operating cash flow exceeds net income: OCF is 1.34x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • Endogenous analysis: Revenue grew +2.1% but receivables grew +16.8% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.
  • 3 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • Market cap $83.82B at $345.27 per share.
  • Trailing P/E 33.65, P/S 3.56, P/B 21.74.
  • Composite risk: Elevated.
  • Leverage debt/equity 2.55 (high).

Filings & ownership

  • Latest annual report (10-K) filed Feb 19, 2026.
  • Latest quarterly report (10-Q) filed Jul 28, 2026.
  • 17 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference Sherwin-Williams; broad institutional reporting.
  • Recent filers include WRIGHT JACKSON W JR TRUSTEE, WRIGHT JACKSON W JR TRUSTEE, WRIGHT JACKSON W JR TRUSTEE.
  • 20 recent 13G passive institutional ownership notices.

Full SHW analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.